| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.2 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | 0.047 | 0.2 |